Zero Gravity Solutions, Inc. Announces Appointment of Raveendran Pottathil, Ph.D. as Chief Technology Officer
BOCA RATON, Fla.— (August 1, 2016) – Zero Gravity Solutions, Inc. (“ZGSI” or the “Company”) (Pink Sheets: ZGSI), an agricultural biotechnology public company commercializing its technology derived from and designed for Space with significant applications for agriculture on Earth, announced today that Raveendran “Ravi” Pottathil, Ph.D. has been appointed Chief Technology Officer (CTO) of the Company.
Dr. Pottathil has an extensive background in applied biology and was formerly Director and Chief Scientific Officer of Merlin Labs (now IDxDI), and Chief Executive Officer of AccuDx Incorporated, a strategic technology and consulting company specializing in platform technology development, technology transfer and intellectual property (IP) protection in the functional food and ecotech industries for major US and international companies. In addition to his experience in the commercialization and roll out of agricultural products, Dr. Pottathil was previously part of the team that developed a new industry standard medical diagnostic kit based upon Polymerase Chain Reaction (PCR) technology while he was at Roche.
“Ravi’s extensive scientific and international business development expertise provides support to our Company’s Chief Science Officer, John Wayne Kennedy, as part of our enhanced scientific team commercializing the Company’s IP based upon our ongoing working relationship with NASA”, stated Harvey Kaye, ZGSI’s Chairman of the Board. Mr. Kaye further stated, “In addition to his technical duties, Ravi has been instrumental in introducing ZGSI’s first commercial product, BAM-FX™, to agricultural markets in multiple countries in Asia, where extensive crop validation trials are currently ongoing and a multi-country distribution network has been established.”
“The capability of BAM-FX to deliver micronutrients like zinc and copper systemically at the cellular level throughout a plant directly addresses a condition known as hidden hunger. Hidden hunger, caused by lack of essential micronutrients in the diet, affects more than half of the world’s population and I am proud to be part of the team working toward a solution to this worldwide problem”, stated Ravi Pottathil, ZGLS’s newly appointed Chief Technology Officer.”
Zero Gravity Solutions, Inc. Announces Appointment of Andrew E. Koopman as President and Chief Executive Officer of Zero Gravity Life Sciences, Inc.
BOCA RATON, Fla.— (July 13, 2016),– Zero Gravity Solutions, Inc. (“ZGSI” or the “Company”) (Pink Sheets: ZGSI), an agricultural biotechnology public company commercializing its technology derived from and designed for Space with significant applications for agriculture on Earth, announced that Andrew E. Koopman has been appointed President and Chief Executive Officer of Zero Gravity Life Sciences, Inc. (ZGLS). ZGLS, a wholly-owned subsidiary of ZGSI, is focused on expanding the Company’s intellectual property related to life sciences. The IP was developed from research conducted on the International Space Station enabled by six NASA missions.
Mr. Koopman’s initial focus is to coordinate the activities of the Company’s expanded scientific team, including our research activities with NASA Ames under the previously announced Space Act Agreement. Mr. Koopman’s responsibilities also include technical support and research to diversify the BAM-FX™ product line, grant and IP strategies and execution.
“Andrew’s background as Director of New Ventures at New York University’s (NYU) Office of Industrial Liaison provides our Company with the unique skill sets required to develop intellectual property into successful commercial business opportunities,” stated Harvey Kaye, ZGSI’s Chairman of the Board.
“After serving as a Scientific Advisor for Zero Gravity Solutions for the previous two years and observing the progress made in development and commercialization of the BAM-FX™ technology, I am excited to join such an extraordinary team. I look forward to leveraging my relationships and applying my experience in the translation of scientific achievements and intellectual property as contribution towards both the achievement of ZGSI’s critical mission and the enhancement of shareholder value”, stated Andrew Koopman, ZGLS’s new President and Chief Executive Officer.